ERBB2 and invasive breast carcinoma: To further investigate molecular differences by race, we analyzed established IBC biomarkers by SRR, including gene expression of ESR1 (ER) and ERBB2 (HER2), as well as the intrinsic subtypes defined by PAM50 in invasive breast cancers.